A. H. Goldstone

1.3k total citations
33 papers, 921 citations indexed

About

A. H. Goldstone is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, A. H. Goldstone has authored 33 papers receiving a total of 921 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 12 papers in Oncology and 10 papers in Genetics. Recurrent topics in A. H. Goldstone's work include Lymphoma Diagnosis and Treatment (9 papers), Acute Myeloid Leukemia Research (7 papers) and Hematopoietic Stem Cell Transplantation (7 papers). A. H. Goldstone is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), Acute Myeloid Leukemia Research (7 papers) and Hematopoietic Stem Cell Transplantation (7 papers). A. H. Goldstone collaborates with scholars based in United Kingdom, France and United States. A. H. Goldstone's co-authors include Stephen Devereux, David C. Linch, Helen Jones, N. Shaun B. Thomas, JG Gribben, Alan K. Burnett, R Zittoun, Maggie Watson, G Harrison and Richard Gray and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

A. H. Goldstone

32 papers receiving 856 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. H. Goldstone United Kingdom 16 397 318 214 170 168 33 921
B Varet France 12 376 0.9× 227 0.7× 194 0.9× 159 0.9× 222 1.3× 46 874
G. J. Ossenkoppele Netherlands 18 309 0.8× 308 1.0× 218 1.0× 164 1.0× 135 0.8× 51 832
Eric M. Bonnem United States 18 344 0.9× 379 1.2× 236 1.1× 172 1.0× 149 0.9× 35 934
Friedrich Schuening United States 21 617 1.6× 198 0.6× 277 1.3× 195 1.1× 174 1.0× 61 1.0k
Stephen J. Forman United States 19 456 1.1× 298 0.9× 203 0.9× 222 1.3× 127 0.8× 34 962
H. Baurmann Germany 18 757 1.9× 211 0.7× 215 1.0× 180 1.1× 170 1.0× 61 1.2k
EF Winton United States 16 323 0.8× 308 1.0× 459 2.1× 200 1.2× 159 0.9× 32 1000
C. Frederick LeMaistre United States 12 282 0.7× 192 0.6× 263 1.2× 93 0.5× 108 0.6× 21 705
Thomas Duell Germany 18 450 1.1× 415 1.3× 216 1.0× 292 1.7× 83 0.5× 48 1.2k
A.-M. Stoppa France 14 537 1.4× 484 1.5× 133 0.6× 218 1.3× 130 0.8× 22 970

Countries citing papers authored by A. H. Goldstone

Since Specialization
Citations

This map shows the geographic impact of A. H. Goldstone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. H. Goldstone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. H. Goldstone more than expected).

Fields of papers citing papers by A. H. Goldstone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. H. Goldstone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. H. Goldstone. The network helps show where A. H. Goldstone may publish in the future.

Co-authorship network of co-authors of A. H. Goldstone

This figure shows the co-authorship network connecting the top 25 collaborators of A. H. Goldstone. A scholar is included among the top collaborators of A. H. Goldstone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. H. Goldstone. A. H. Goldstone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bowen, H. J. M., et al.. (2011). Generation of a high affinity Phl p 7-specific IgG4 antibody. Clinical & Experimental Allergy. 41(12). 1832–1832. 1 indexed citations
2.
3.
Laurence, Arian & A. H. Goldstone. (1999). High-dose therapy with hematopoietic transplantation for Hodgkin's lymphoma.. PubMed. 36(3). 303–12. 6 indexed citations
5.
Nokes, Tim, Stephen A. Johnson, Danielle Harvey, & A. H. Goldstone. (1997). FLAG is a Useful Regimen for Poor Prognosis Adult Myeloid Leukaemias and Myelodysplastic Syndromes. Leukemia & lymphoma. 27(1-2). 93–101. 35 indexed citations
6.
Mills, Wendy, R Chatterjee, H H McGarrigle, David C. Linch, & A. H. Goldstone. (1994). Partial hypopituitarism following total body irradiation in adult patients with haematological malignancy.. PubMed. 14(3). 471–3. 3 indexed citations
7.
Ehrenstein, Michael R., et al.. (1993). Appearance of anti‐DNA antibodies in patients treated with interferon‐α. Arthritis & Rheumatism. 36(2). 279–280. 43 indexed citations
8.
Worman, C. P., A. Victor Hoffbrand, D W Milligan, et al.. (1993). Low-Dose Recombinant Alfa-2a-lnterferon: A Feasible Maintenance Therapy in Acute Myeloid Leukaemia in the Older Patient. Acta Haematologica. 89(1). 1–5. 8 indexed citations
9.
Giles, Frank, John Richards, Jeffrey Tobias, et al.. (1992). Prospective randomised study of double hemi-body irradiation with and without subsequent maintenance recombinant alpha 2b interferon on survival in patients with relapsed multiple myeloma. European Journal of Cancer. 28(8-9). 1392–1395. 10 indexed citations
10.
Giles, Francis J., Michael P. Smith, & A. H. Goldstone. (1990). Chlorambucil Lung Toxicity. Acta Haematologica. 83(3). 156–158. 10 indexed citations
11.
Hoffbrand, A. V., et al.. (1990). Alpha interferon therapy for haematological malignancies: correlation between in vivo induction of the 2′,5′ oligoadenylate system and clinical response. British Journal of Haematology. 74(4). 452–456. 17 indexed citations
12.
Gribben, JG, Stephen Devereux, N. Shaun B. Thomas, et al.. (1990). Development of antibodies to unprotected glycosylation sites on recombinant human GM-CSF. The Lancet. 335(8687). 434–437. 156 indexed citations
13.
Giles, Frank, Joseph Kearney, Michael J. Mills, et al.. (1990). Systemic Irradiation Therapy of Myelomatosis—The Therapeutic Implications of Technique. Leukemia & lymphoma. 1(3-4). 227–233. 3 indexed citations
14.
Giles, Francis J., M Brozović, Irene R. Grant, et al.. (1988). ALPHA-INTERFERON THERAPY FOR ESSENTIAL THROMBOCYTHAEMIA. The Lancet. 332(8602). 70–72. 74 indexed citations
15.
Goldstone, A. H. & John G. Gribben. (1987). The role of autologous bone marrow transplantation in the treatment of malignant disease. Blood Reviews. 1(3). 193–200. 4 indexed citations
16.
Walker, Helen M., Charles R.J. Singer, J. Patterson, A. H. Goldstone, & H. G. Prentice. (1986). The significance of host haemopoietic cells detected by cytogenetic analysis of bone marrow from recipients of bone marrow transplants. British Journal of Haematology. 62(2). 385–391. 46 indexed citations
17.
Gorin, NC, P Hervé, Philippe Aegerter, et al.. (1986). Autologous bone marrow transplantation for acute leukaemia in remission. British Journal of Haematology. 64(2). 385–395. 54 indexed citations
18.
Souhami, R L, Walter M. Gregory, Robert Buckman, et al.. (1985). High-dose cyclophosphamide in small-cell carcinoma of the lung.. Journal of Clinical Oncology. 3(7). 958–963. 56 indexed citations
19.
Patterson, K.G., A. H. Goldstone, J.D.M. Richards, & John C. Cawley. (1982). Increased Neutrophil Peroxidase Activity in Acute Myeloid Leukaemia. Acta Haematologica. 68(4). 261–267. 1 indexed citations
20.
Baum, Michael, et al.. (1982). Effect of surgery on monocyte function. British journal of surgery. 69(3). 145–146. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026